On 23 March 2016 the Access to Medical Treatments (Innovation) Act 2016 received Royal Assent. (England and Wales).
The content of the legislation changed from that originally suggested by Lord Saatchi. It’s final form appears not to be online yet, but the Bill provided that its purpose was to promote access to innovative medical treatments (including treatments consisting in the off-label use of medicines or the use of unlicensed medicines) by providing for the establishment of a database of innovative medical treatments and access to information contained in the database.
The core of the legislation (section 2) appears to be the granting of power to the Secretary of State by regulations to make provision conferring functions on the Health and Social Care Information Centre (“the HSCIC”) in connection with the establishment, maintenance and operation of a database containing information about innovative medical treatments carried out by doctors in England, and the results of such treatments.
Section 2(2) provides that “innovative medical treatment” means medical treatment for a
condition that involves a departure from the existing range of accepted medical treatments for the condition.